News | May 30, 2023
Hikal posts FY23 PAT at Rs. 36 Cr
Pharmaceutical sales was flat and stood at Rs. 309 crore as compared to Rs. 308 crore in Q4 FY22
Pharmaceutical sales was flat and stood at Rs. 309 crore as compared to Rs. 308 crore in Q4 FY22
Aim of the agreement is to expand the full potential of Beren’s cyclodextrin technologies and their medicinal applications.
China recorded unprecedented improvement in its API manufacturing score in the 2022 end of year CPHI Survey
Wearable patch sensors (smart patches) are rising in popularity, as they offer a wide range of options for medical diagnosis
Saransh Chaudhary, President, Global Critical Care Division, Venus Remedies and CEO, Venus Medicine Research Centre In conversation with Thomas C Thottathil, Editor, www.indianpharmapost.com identified key areas that the company is focusing on in its Mission 2025
The capex during the last nine months has been around Rs 110 crores which is all funded through internal accruals
The investment programme is expected to significantly reduce commercialisation lead times, costs and introduce more sustainable manufacturing processes
The Bidar API manufacturing facility of Sai Life Sciences has been on a path of significant expansion with its production capacity growing from 200KL in 2017 to 450KL
Subscribe To Our Newsletter & Stay Updated
